Test Price
2,800 AED✅ Home Collection Available
B9D2 Gene Meckel Syndrome Type 10 Next-Generation Sequencing (NGS) Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
This advanced genetic test provides a precise molecular diagnosis for pathogenic variants in the B9D2 gene associated with Meckel syndrome type 10, a severe autosomal recessive ciliopathy. The test employs Next-Generation Sequencing with Sanger validation to achieve 99.9% diagnostic sensitivity.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The B9D2 gene NGS test detects pathogenic variants in the B9D2 gene responsible for Meckel syndrome type 10 (MKS10). This ciliopathy primarily affects renal, hepatic, and central nervous system development. Our panel provides full gene coverage including copy number variation (CNV) detection, validated by Sanger sequencing for confirmation.
| Feature | Our Test (NGS Panel) | Closest Alternative (Single-Gene Sanger) |
|---|---|---|
| Precision | Full gene coverage with CNV detection | Limited to known mutations |
| Methodology | Next-Generation Sequencing (NGS) + Sanger validation | Sanger sequencing of select exons |
| Turnaround | 3 to 4 Weeks | 6–8 Weeks (batch-dependent) |
Physician Insight & Safety Protocols
“Genetic results must be interpreted alongside clinical, biochemical, and imaging data. A negative NGS result does not rule out Meckel syndrome type 10 if the clinical picture is strongly suggestive. Positive findings warrant comprehensive genetic counselling and family cascade testing. Always consult your managing physician before altering any prescribed treatment plan.” – Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory – Medication and Clinical Management
Do not discontinue any prescribed medication or deviate from your current clinical management without explicit advice from your doctor. This test is a diagnostic adjunct, not a substitute for ongoing specialist care.
Exclusion Criteria & Emergency Red Flags
- Bone marrow transplant within the last 6 weeks (donor DNA interference).
- Severe leukopenia (WBC <1.0 x10⁹/L) or coagulopathy precluding safe venipuncture.
- Genetic testing of minors without valid parental/guardian consent as per UAE Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Urgent medical attention needed if: sudden flank pain, macroscopic hematuria, jaundice, progressive abdominal distension, or signs of acute liver failure. This test is diagnostic—not for acute emergency management.
Patient FAQ & Clinical Guidance
1. What is the B9D2 gene test for?
The B9D2 gene NGS test identifies mutations causing Meckel syndrome type 10, aiding in diagnosis, carrier screening, and family planning with 99.9% sensitivity.
2. How long does the test take and what sample is required?
Results are typically available in 3 to 4 weeks from a blood sample, extracted DNA, or dried blood spot on an FTA card.
3. Is this covered by health insurance in the UAE?
Many UAE insurance plans cover genetic testing; contact our team via WhatsApp at +971 54 548 8731 for direct billing verification and pre-approval assistance.
4. Can home collection be arranged?
Yes, a VIP Mobile Phlebotomy and temperature-controlled cold-chain home collection service is available daily from 8 AM to 11 PM for standard blood specimens.
UAE Regulatory & Data Privacy Adherence
This test is performed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. The laboratory is ISO 9001:2015 certified and operates under DHA Facility License No. 1143.
Clinical & Logistical Metadata
| Test Name | B9D2 Gene Meckel Syndrome Type 10 NGS Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card) |
| Methodology Used | Next-Generation Sequencing (NGS) with Sanger validation |
| ICD-10-CM Code | Q61.9 |
| LOINC Code | 92822-6 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians